"The depth and breadth of expertise available through Gerson Lehrman Group is a great fit for BIO's continuing efforts to provide cutting-edge education to our conference registrants, who themselves are some of the most informed healthcare industry experts," said Jim Greenwood, President and Chief Executive Officer of BIO. "Workshops selected for the BIO National Venture Conference are representative of the most compelling topics for biotechnology venture start-ups today, and focus on educating investors and industry on the latest areas of pipeline innovation, as well as strategies for capitalization and supporting product development objectives."
The first annual BIO National Venture Conference will feature select early-stage private biotechnology companies from across the U.S. The goal of this new national meeting is to bring together an elite group of healthcare venture partners for a concentrated one and a half day event. Workshops and plenary sessions on trends in the industry will also be held, with special focus on key success factors for early-stage companies, market trends, and financing. In addition, there will be formal and informal networking opportunities with industry CEOs and venture capital leaders.
To see the latest updates to 2008 programming and speakers for BIO National Venture Conference, please visit http://bnvc.bio.org.
About Gerson Lehrman Group
Gerson Lehrman Group provides technology and services to support a
marketplace for expertise. Since 1998, its platform for consultation and
collaboration has helped the world's leading financial services firms,
consultancies, corporations, and nonprofits find, engage, and manage
experts in a broad range of industries and disciplines. Gerson Lehrman
|SOURCE Gerson Lehrman Group|
Copyright©2008 PR Newswire.
All rights reserved